Approval · Notice of Compliance 33974 · 2024
CYTOSAR: Notice of Compliance 33974
Issued September 10, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33974
- Date
- September 10, 2024
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Mise à jour de la monographie de produit avec de n ouveaux renseignements relatifs à l'efficacité. Change in the drug product manufacturing process. Addition of a primary container closure system. Update to package labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CYTOSAR | Not yet assigned | — |
Medicinal ingredients
- CYTARABINE 100 MG per ML